SLC5A2 and type 2 diabetes mellitus: To gain insight into the effects of SGLT2 inhibitors on glucose metabolism, we have now mathematically analyzed hormonal and glycemia data obtained during a hyperinsulinemic-euglycemic clamp from individuals with type 2 diabetes under treatment with the SGLT2 inhibitor dapagliflozin.